The Post IPO Growth Plan

By Equifund

This webinar is brought to you by Equifund Technologies, LLC.

As a Pre-IPO investor, it’s critical you understand how to answer the question “what do I do once the company goes public?”

This webinar is designed to help you get a big picture view of the challenges public companies face and it means for you, the investor.

Aside from that, we’ll also reveal answers to common questions like:

  • Why does the “IPO Pop” happen (and how might I profit from it?).
  • Do I have to sell my shares once the company goes public? Or can I hold onto them and sell them later?
  • How does the 6 month lock-up work? And am I going to be locked up when the company goes public?
  • How do I decide when to sell (if at all)?
  • And why you need to have your brokerage accounts opened well in advance of a company going public (and how to handle depositing shares)

And if you haven’t already, please read our detailed guide on depositing your shares into brokerage by clicking here.

We can’t stress enough how important it is for you to familiarize yourself with this process.

Yes, it does involve doing some manual work to get shares into the system…

But this is – by far – the most common question we get asked by our members.

More Articles:

Don't make another private market investment without reading this...

The 5 Mistakes

investors make that crush returns

Download this free report now:

Just enter your name & email to access this report for free.

By submitting your email address you will receive access to this report and a free subscription to Equifund’s private investment newsletter. You can unsubscribe at any time and read more about our privacy policy here.

More Articles:

Advertisement:

Kleiner Device Labs

Investment Highlights:

  • 1

    Proprietary devices that could revolutionize spinal surgery and greatly improve success rates, reduce pain, and lower costs.

  • 2

    Over 20 patents have been issued to protect the company's technologies.

  • 3

    Just received FDA clearance for their next-generation KG2 spinal fusion technology.